|
× |
 |
Effectiveness of Aripiprazole, Olanzapine, Quetiapine, and Risperidone Augmentation Treatment for Major Depressive Disorder: A Nationwide Population-Based Study PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Controlled-Release Fluvoxamine in Patients With Obsessive-Compulsive Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
The US Food and Drug Administration's Perspective on the New Antidepressant Vortioxetine PDF |
$40.00 |
|
$40.00 |
|
× |
|
Risk Factors for Violent Crime in Schizophrenia: A National Cohort Study of 13,806 Patients PDF |
$40.00 |
|
$40.00 |
|
|
